The Next Phase of Human Gene-Therapy Oversight

The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) have played key roles in the emergence of safe and effective human gene therapies. Now, we are proposing new efforts to encourage further advances in this rapidly evolving field. The potential to alter human genes…

Read the full post on The New England Journal of Medicine: Search Results in Health Policy and Reform